Cargando…
Metformin Decreases Serum Thyroglobulin Concentration in Nonmedullary Thyroid Carcinoma
CONTEXT: The conventional treatment of nonmedullary thyroid carcinoma (NMTC) includes surgical resection, thyrotropin (TSH) suppression, and 131-iodine. Some patients develop persistent/recurrent metastatic disease requiring expensive alternative therapies, such as external radiation and multikinase...
Autores principales: | Caetano, Celina, Pico, Paola Tabaro, Singh, Charan, Tendler, Beatriz, Malchoff, Diana M, Malchoff, Carl D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577541/ https://www.ncbi.nlm.nih.gov/pubmed/36267597 http://dx.doi.org/10.1210/jendso/bvac140 |
Ejemplares similares
-
PSAT373 Metformin Decreases Serum Thyroglobulin Concentration in Non-Medullary Thyroid Carcinoma
por: Caetano, Celina, et al.
Publicado: (2022) -
SAT-020 Empiric Determination of Daily Glucocorticoid Replacement Doses in Adrenal Insufficiency
por: Caetano, Celina, et al.
Publicado: (2019) -
Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review
por: Caetano, Celina M., et al.
Publicado: (2022) -
Adrenal vein sampling with and without cosyntropin stimulation for detection of surgically remediable aldosteronism
por: Violari, Elena G., et al.
Publicado: (2019) -
Serum Calcium and Risk of Nonmedullary Thyroid Cancer in Patients with Primary Hyperparathyroidism
por: Xue, Ying, et al.
Publicado: (2016)